| 1 |
Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian- adnexal reporting and data system committee [J]. Radiology, 2020, 294(1): 168-185.
|
| 2 |
陈程, 戴晴. 美国放射学会卵巢-附件影像报告和数据系统超声风险分层与管理共识指南的解读 [J/OL]. 中华医学超声杂志 (电子版), 2020, 17(11): 1151-1060.
|
| 3 |
Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer [J]. Br J Obstet Gynaecol, 1990, 97(10): 922-929.
|
| 4 |
DePriest PD, Shenson D, Fried A, et al. A morphology index based on sonographic findings in ovarian cancer [J]. Gynecol Oncol, 1993, 51(1): 7-11.
|
| 5 |
Ueland FR, DePriest PD, Pavlik EJ, et al. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography [J]. Gynecol Oncol, 2003, 91(1): 46-50.
|
| 6 |
Elder JW, Pavlik EJ, Long A, et al. Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index [J]. Gynecol Oncol, 2014, 135(1): 8-12.
|
| 7 |
Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group [J]. Ultrasound Obstet Gynecol, 2000, 16(5): 500-505.
|
| 8 |
Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer [J]. Ultrasound Obstet Gynecol, 2008, 31(6): 681-690.
|
| 9 |
Van Calster B, Van Hoorde K, Valentin L, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumors: prospective multicenter diagnosticstudy [J]. BMJ, 2014, 349: g5920.
|
| 10 |
Timmerman D, Van Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis Group [J]. Am J Obstet Gynecol, 2016, 214(4): 424-437.
|
| 11 |
Amor F, Vaccaro H, Alcázar JL, et al. Gynecologic imaging reporting and data system: a new proposal for classifying adnexal masses on the basis of sonographic findings [J]. J Ultrasound Med, 2009, 28(3): 285-291.
|
| 12 |
Amor F, Alcázar JL, Vaccaro H, et al. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study [J]. Ultrasound Obstet Gynecol, 2011, 38(4): 450-455.
|
| 13 |
Levine D, Brown DL, Andreotti RF, et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement [J]. Radiology, 2010, 256(3): 943-954.
|
| 14 |
Andreotti RF, Timmerman D, Benacerraf BR, et al. Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian Adnexal Reporting and Data System Committee [J]. J Am Coll Radiol, 2018, 15(10): 1415-1429.
|
| 15 |
Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group [J]. J Clin Oncol, 2005, 23(34): 8794-8801.
|
| 16 |
Szubert S, Wojtowicz A, Moszynski R, et al. External validation of the IOTA ADNEX model performed by two independent gynecologic centers [J]. Gynecol Oncol, 2016, 142(3): 490-495.
|
| 17 |
Sayasneh A, Ferrara L, De Cock B, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study [J]. Br J Cancer, 2016, 115(5): 542-548.
|
| 18 |
Patel MD, Acord DL, Young SW. Likelihood ratio of sonographic findings in discriminating hydrosalpinx from other adnexal masses [J]. AJR Am J Roentgenol, 2006, 186(4): 1033-1038.
|
| 19 |
Smith-Bindman R, Poder L, Johnson E, et al. Risk of malignant ovarian cancer based on ultrasonography findings in a large unselected population [J]. JAMA Intern Med, 2019, 179(1): 71-77.
|
| 20 |
Greenlee RT, Kessel B, Williams CR, et al. Prevalence, incidence, and natural history of simple ovarian cysts among women. 55 years old in a large cancer screening trial [J]. Am J Obstet Gynecol, 2010, 202(4): 373.e1-373.e9.
|
| 21 |
Sharma A, Apostolidou S, Burnell M, et al. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS) [J]. Ultrasound Obstet Gynecol, 2012, 40(3): 338-344.
|
| 22 |
Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial [J]. Lancet, 2016, 387(10022): 945-956.
|
| 23 |
Modesitt SC, Pavlik EJ, Ueland FR, et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter [J]. Obstet Gynecol, 2003, 102(3): 594-599.
|
| 24 |
van Nagell JRJr, DePriest PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened [J]. Cancer, 2007, 109(9): 1887-1896.
|
| 25 |
Van Holsbeke C, Van Calster B, Guerriero S, et al. Endometriomas: their ultrasound characteristics [J]. Ultrasound Obstet Gynecol, 2010, 35(6): 730-740.
|
| 26 |
Practice Bulletin No. 174 Summary: Evaluation and management of adnexal masses [J]. Obstet Gynecol, 2016, 128(5): 1193-1195.
|
| 27 |
Froyman W, Landolfo C, De Cock B, et al. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study [J]. Lancet Oncol, 2019, 20(3): 448-458.
|
| 28 |
Froyman W, Wynants L, Landolfo C, et al. Validation of the performance of International Ovarian Tumor Analysis (IOTA) methods in the diagnosis of early stage ovarian cancer in a non-screening population [J]. Diagnostics (Basel), 2017, 7(2): E32.
|